当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析 - 现金流量表

同和药业

(300636)

  

流通市值:22.04亿  总市值:25.20亿
流通股本:3.67亿   总股本:4.20亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金532,586,433.96339,151,129.55163,052,924.02749,491,411.77
  收到的税费返还51,928,293.8839,436,480.7623,407,529.653,679,946.99
  收到其他与经营活动有关的现金50,246,687.9625,242,995.447,824,213.9326,966,162.51
  经营活动现金流入小计634,761,415.8403,830,605.75194,284,667.55830,137,521.27
  购买商品、接受劳务支付的现金275,438,164.63176,557,186.0597,708,069.04414,309,194.97
  支付给职工以及为职工支付的现金153,184,719.83102,985,902.7656,772,888.48177,700,710.71
  支付的各项税费6,193,766.133,513,272.121,264,573.457,130,309.23
  支付其他与经营活动有关的现金37,733,176.629,652,568.916,076,481.6828,926,568.85
  经营活动现金流出小计472,549,827.19312,708,929.83171,822,012.65628,066,783.76
  经营活动产生的现金流量净额162,211,588.6191,121,675.9222,462,654.9202,070,737.51
二、投资活动产生的现金流量:
  收回投资收到的现金867,237,493.21454,192,290.36164,103,194.45599,278,710.77
  取得投资收益收到的现金624,637.38376,560.55107,243.84367,655.14
  处置固定资产、无形资产和其他长期资产收回的现金净额439,297.66304,108.2667,081.06391,656.81
  投资活动现金流入小计868,301,428.25454,872,959.17164,277,519.35600,038,022.72
  购建固定资产、无形资产和其他长期资产支付的现金162,521,058.8599,618,131.5258,450,699.09291,242,885.75
  投资支付的现金496,871,547.3311,014,003.1239,747,123.3325,703,888.9
  投资活动现金流出小计659,392,606.15410,632,134.62298,197,822.39616,946,774.65
  投资活动产生的现金流量净额208,908,822.144,240,824.55-133,920,303.04-16,908,751.93
三、筹资活动产生的现金流量:
  取得借款收到的现金228,149,653122,997,05359,712,000459,890,512.13
  收到其他与筹资活动有关的现金---10,000,000
  筹资活动现金流入小计228,149,653122,997,05359,712,000469,890,512.13
  偿还债务支付的现金682,733,421.26306,223,059.1383,847,309.13525,620,000
  分配股利、利润或偿付利息支付的现金23,350,051.2621,867,837.532,631,324.7828,778,546.99
  支付其他与筹资活动有关的现金742,167.2463,854.5185,541.813,456,481.1
  筹资活动现金流出小计706,825,639.72328,554,751.1686,664,175.71567,855,028.09
  筹资活动产生的现金流量净额-478,675,986.72-205,557,698.16-26,952,175.71-97,964,515.96
四、汇率变动对现金及现金等价物的影响-8,156,247.95-6,535,543.07-4,187,012.02233,576.1
五、现金及现金等价物净增加额-115,711,823.96-76,730,740.76-142,596,835.8787,431,045.72
  加:期初现金及现金等价物余额252,843,283.48252,843,283.48252,843,283.48165,412,237.76
  期末现金及现金等价物余额137,131,459.52176,112,542.72110,246,447.61252,843,283.48
补充资料:
  净利润-24,570,982.63-73,091,433.31
  资产减值准备-12,549,396.58-63,655,296.94
  固定资产和投资性房地产折旧-71,044,031.63-129,453,490
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,044,031.63-129,453,490
  无形资产摊销-386,310.73-866,186.24
  长期待摊费用摊销---509,569.02
  处置固定资产、无形资产和其他长期资产的损失-63,554.06-767,628.83
  公允价值变动损失----214,316.67
  财务费用-13,745,050.22-12,413,025.03
  投资损失--162,777.21-1,116,706.88
  递延所得税--4,010,303.99-2,259,244.38
  其中:递延所得税资产减少--5,678,187.53-11,079,513.84
    递延所得税负债增加-1,667,883.54--8,820,269.46
  存货的减少--53,258,772.61--20,125,235.98
  经营性应收项目的减少--29,333,360.9--37,197,879.57
  经营性应付项目的增加-54,534,359.97-31,454,595.14
  其他-568,770.81--56,827,874.04
  现金的期末余额-176,112,542.72-252,843,283.48
  减:现金的期初余额-252,843,283.48-165,412,237.76
  现金及现金等价物的净增加额--76,730,740.76-87,431,045.72
公告日期2026-10-292026-08-262026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑